These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 27161030)

  • 1. Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release.
    Manotheepan R; Danielsen TK; Sadredini M; Anderson ME; Carlson CR; Lehnart SE; Sjaastad I; Stokke MK
    Cardiovasc Res; 2016 Aug; 111(3):295-306. PubMed ID: 27161030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oxidation-resistant CaMKII-MM281/282VV mutation does not prevent arrhythmias in CPVT1.
    Sadredini M; Manotheepan R; Lehnart SE; Anderson ME; Sjaastad I; Stokke MK
    Physiol Rep; 2021 Sep; 9(18):e15030. PubMed ID: 34558218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CaMKII inhibition has dual effects on spontaneous Ca
    Sadredini M; Haugsten Hansen M; Frisk M; Louch WE; Lehnart SE; Sjaastad I; Stokke MK
    Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H446-H460. PubMed ID: 34270372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmia initiation in catecholaminergic polymorphic ventricular tachycardia type 1 depends on both heart rate and sympathetic stimulation.
    Danielsen TK; Manotheepan R; Sadredini M; Leren IS; Edwards AG; Vincent KP; Lehnart SE; Sejersted OM; Sjaastad I; Haugaa KH; Stokke MK
    PLoS One; 2018; 13(11):e0207100. PubMed ID: 30399185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.
    Uchinoumi H; Yano M; Suetomi T; Ono M; Xu X; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ohkusa T; Ikemoto N; Matsuzaki M
    Circ Res; 2010 Apr; 106(8):1413-24. PubMed ID: 20224043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
    Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814.
    Mazzocchi G; Sommese L; Palomeque J; Felice JI; Di Carlo MN; Fainstein D; Gonzalez P; Contreras P; Skapura D; McCauley MD; Lascano EC; Negroni JA; Kranias EG; Wehrens XH; Valverde CA; Mattiazzi A
    J Physiol; 2016 Jun; 594(11):3005-30. PubMed ID: 26695843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+/calmodulin-dependent kinase IIδC-induced chronic heart failure does not depend on sarcoplasmic reticulum Ca2+ leak.
    Dewenter M; Seitz T; Steinbrecher JH; Westenbrink BD; Ling H; Lehnart SE; Wehrens XHT; Backs J; Brown JH; Maier LS; Neef S
    ESC Heart Fail; 2024 Aug; 11(4):2191-2199. PubMed ID: 38616546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift.
    Uchinoumi H; Yang Y; Oda T; Li N; Alsina KM; Puglisi JL; Chen-Izu Y; Cornea RL; Wehrens XHT; Bers DM
    J Mol Cell Cardiol; 2016 Sep; 98():62-72. PubMed ID: 27318036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholamban knockout breaks arrhythmogenic Ca²⁺ waves and suppresses catecholaminergic polymorphic ventricular tachycardia in mice.
    Bai Y; Jones PP; Guo J; Zhong X; Clark RB; Zhou Q; Wang R; Vallmitjana A; Benitez R; Hove-Madsen L; Semeniuk L; Guo A; Song LS; Duff HJ; Chen SR
    Circ Res; 2013 Aug; 113(5):517-26. PubMed ID: 23856523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated local [Ca2+] and CaMKII promote spontaneous Ca2+ release in ankyrin-B-deficient hearts.
    Popescu I; Galice S; Mohler PJ; Despa S
    Cardiovasc Res; 2016 Aug; 111(3):287-94. PubMed ID: 27131508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CaMKII phosphorylation of RyR2 prevents inducible ventricular arrhythmias in mice with Duchenne muscular dystrophy.
    Ather S; Wang W; Wang Q; Li N; Anderson ME; Wehrens XH
    Heart Rhythm; 2013 Apr; 10(4):592-9. PubMed ID: 23246599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
    Valverde CA; Mazzocchi G; Di Carlo MN; Ciocci Pardo A; Salas N; Ragone MI; Felice JI; Cely-Ortiz A; Consolini AE; Portiansky E; Mosca S; Kranias EG; Wehrens XHT; Mattiazzi A
    Cardiovasc Res; 2019 Mar; 115(3):556-569. PubMed ID: 30169578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia.
    Liu N; Ruan Y; Denegri M; Bachetti T; Li Y; Colombi B; Napolitano C; Coetzee WA; Priori SG
    J Mol Cell Cardiol; 2011 Jan; 50(1):214-22. PubMed ID: 20937285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
    Shan J; Xie W; Betzenhauser M; Reiken S; Chen BX; Wronska A; Marks AR
    Circ Res; 2012 Aug; 111(6):708-17. PubMed ID: 22828895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell-derived cardiomyocytes: Comparison of RyR2-R420Q, F2483I, and Q4201R.
    Zhang XH; Wei H; Xia Y; Morad M
    Heart Rhythm; 2021 Feb; 18(2):250-260. PubMed ID: 32931925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium/calmodulin-dependent kinase II and nitric oxide synthase 1-dependent modulation of ryanodine receptors during β-adrenergic stimulation is restricted to the dyadic cleft.
    Dries E; Santiago DJ; Johnson DM; Gilbert G; Holemans P; Korte SM; Roderick HL; Sipido KR
    J Physiol; 2016 Oct; 594(20):5923-5939. PubMed ID: 27121757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.
    Neco P; Torrente AG; Mesirca P; Zorio E; Liu N; Priori SG; Napolitano C; Richard S; Benitah JP; Mangoni ME; Gómez AM
    Circulation; 2012 Jul; 126(4):392-401. PubMed ID: 22711277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
    Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
    Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of individualized exercise training in patients with catecholaminergic polymorphic ventricular tachycardia type 1.
    Manotheepan R; Saberniak J; Danielsen TK; Edvardsen T; Sjaastad I; Haugaa KH; Stokke MK
    Am J Cardiol; 2014 Jun; 113(11):1829-33. PubMed ID: 24837260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.